A Study of Baricitinib in Participants With Rheumatoid Arthritis

NCT04086745 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1317

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Baricitinib
DRUG: TNF Inhibitor

Sponsor

Eli Lilly and Company

Collaborators

[object Object]